4DMedical Ltd.

4DMedical Ltd.'s next confirmed earnings release is scheduled for February 26, 2027.

As of June 30, 2025, 4DMedical Ltd. has 465.54M shares outstanding.

As of June 30, 2025, 4DMedical Ltd. maintains a current ratio of 0.89, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.71, indicating elevated leverage, while an interest coverage ratio of -4,879.85 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2025, 4DMedical Ltd. posted a negative return on equity (ROE) of -44.49, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -27.77, reflecting losses generated across the asset base. The company generates approximately 26,023.50 in revenue per employee across its workforce of 124.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.32 indicates how many times 4DMedical Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2025, 4DMedical Ltd. recorded an income tax benefit of -48,650.54 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -16.84M and -16.79M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

These figures are as of the close on October 22, 2026.

Over the twelve months ended June 30, 2025, 4DMedical Ltd. generated 3.23M in revenue and converted that into -16.79M in net income, yielding earnings per share of -0.08. EBITDA reached -23.59M, while operating income came in at -26.57M.

As of June 30, 2025, 4DMedical Ltd. holds 3.84M in cash and equivalents against 2.41M in total debt, resulting in a net debt position of -3.84M. Total book value stands at 35.87M, with working capital of -1.22M providing operational flexibility.

These figures cover the twelve months ended June 30, 2025.

Over the twelve months ended June 30, 2025, 4DMedical Ltd. posted a gross margin of 91.96, reflecting its pricing power and cost economics. The operating margin of -823.32 and net profit margin of -520.38 provide insight into operational efficiency.